US Trade Representative Katherine Tai met virtually on Monday with executives at pharmaceutical company Pfizer. (PFE.N) And AstraZeneca PLC ((AZN).L) Discuss certain intellectual property waivers proposed in response to the COVID-19 pandemic.
Members of the World Trade Organization will discuss India and South Africa’s proposal to waive certain provisions of the WTO’s Trade-Related Aspects of Intellectual Property Agreement (TRIPS) on April 30, but the United States and others. Several large countries have blocked such a move.
Democrats, civil society groups, 60 former chiefs, and 100 Nobel laureates are calling on President Joe Biden to support the exemption. White House spokesman Jen Psaki said Monday that there was no up-to-date information on the issue.
Earlier this month, Thailand told the WTO that the gap in access to medicines between developed and developing countries was “totally unacceptable” and the industry had to make sacrifices in the event of a crisis. ..
In discussions with Pfizer CEO Dr. Albert Bourla, Thailand emphasized its commitment to working with other members of the WTO on a global response to the crisis, her office said. Said in a statement.
This includes “the role of developing countries in all solutions to address significant gaps in the global production and distribution of vaccines,” the USTR said.
Thailand also discusses this issue with Dr. Ludo Dober, AstraZeneca’s U.S. Operations Director, on the White House’s decision to share up to 60 million doses of AstraZeneca’s COVID-19 vaccine with countries in need. I did. read more
The USTR said Tai and Dobber had discussed “increased vaccine production, global health problems, and proposed exemptions.”
Our criteria: Thomson Reuters trusts the principles.